The benefits and harms of breast cancer screening: an independent review

MG Marmot, DG Altman, DA Cameron, JA Dewar… - British journal of …, 2013 - nature.com
The breast cancer screening programmes in the United Kingdom currently invite women
aged 50–70 years for screening mammography every 3 years. Since the time the screening …

Benefits and harms of mammography screening

M Løberg, ML Lousdal, M Bretthauer, M Kalager - Breast cancer research, 2015 - Springer
Mammography screening for breast cancer is widely available in many countries. Initially
praised as a universal achievement to improve women's health and to reduce the burden of …

International evaluation of an AI system for breast cancer screening

SM McKinney, M Sieniek, V Godbole, J Godwin… - Nature, 2020 - nature.com
Screening mammography aims to identify breast cancer at earlier stages of the disease,
when treatment can be more successful. Despite the existence of screening programmes …

Screening for breast cancer: US Preventive Services Task Force recommendation statement

AL Siu… - Annals of internal …, 2016 - acpjournals.org
Description: Update of the 2009 US Preventive Services Task Force (USPSTF)
recommendation on screening for breast cancer. Methods: The USPSTF reviewed the …

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

E Senkus, S Kyriakides, S Ohno… - Annals of …, 2015 - annalsofoncology.org
In 2012, the estimated age-adjusted annual incidence of breast cancer in 40 European
countries was 94.2/100 000 and the mortality 23.1/100 000 [1]. The incidence increased …

[HTML][HTML] Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory

M Arnold, HE Karim-Kos, JW Coebergh… - European journal of …, 2015 - Elsevier
Background Individual country-and cancer site-specific studies suggest that the age-
adjusted incidence of many common cancers has increased in European populations over …

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

E Senkus, S Kyriakides, F Penault-Llorca… - Annals of …, 2013 - annalsofoncology.org
In 2008, the estimated age-adjusted annual incidence of breast cancer in Europe (40
countries) was 88.4/100 000 and the mortality 24.3/100 000. The incidence increased after …

Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality

A Dibden, J Offman, SW Duffy, R Gabe - Cancers, 2020 - mdpi.com
In 2012, the Euroscreen project published a review of incidence-based mortality evaluations
of breast cancer screening programmes. In this paper, we update this review to October …

Identifying normal mammograms in a large screening population using artificial intelligence

K Lång, M Dustler, V Dahlblom, A Åkesson… - European …, 2021 - Springer
Objectives To evaluate the potential of artificial intelligence (AI) to identify normal
mammograms in a screening population. Methods In this retrospective study, 9581 double …

Real-time monitoring of results during first year of Dutch colorectal cancer screening program and optimization by altering fecal immunochemical test cut-off levels

E Toes-Zoutendijk, ME van Leerdam, E Dekker… - Gastroenterology, 2017 - Elsevier
Background & Aims After careful pilot studies and planning, the national screening program
for colorectal cancer (CRC), with biennial fecal immunochemical tests (FITs), was initiated in …